研究業績（論文）
2026年
Reduced Soluble Ubiquilin2 in Amyotrophic Lateral Sclerosis Carrying Ubiquilin2 (P494L) Mutation: Clinicopathological and Biochemical Evidence From an Autopsy Case.
Adachi T, Nakano T, Yoshida K, Suzuki Y, Sakuwa M, Hasegawa M, Jannah AR, Hara N, Miyashita A, Ikeuchi T, Hanajima R. Neuropathol Appl Neurobiol. 2026 Aug;52(4):e70091. doi: 10.1111/nan.70091.
2025年
Anti-Signal Recognition Particle Antibody-Positive Immune-Mediated Necrotizing Myopathy Diagnosed by Re-Evaluation 40 Years After Symptom Onset.
Yoshida K, Adachi T, Suzuki S, Nishino I, Hanajima R.
Neuropathology. 2025 Dec;45(6):e70034. doi: 10.1111/neup.70034.
Primary Spinal Cord Glioblastoma Initially Misdiagnosed Inflammatory Demyelinating Disease
Mayuko Sakuwa, Tadashi Adachi, Kentaro Yoshida, Yuki Suzuki, Karen Makishima, Yutaka Suto, Hiroki Fukuda, Yoshito Hosoda, Takuya Furuta, Ritsuko Hanajima
Neurology and Clinical Neuroscience.2025
2024年
Psychiatric symptoms and TDP-43 pathology in amyotrophic lateral sclerosis.
Yuki Suzuki, Tadashi Adachi, Kentaro Yoshida, Mayuko Sakuwa, Ritsuko Hanajima.J Neurol Sci. 2024 Sep 18:466:123249.
Corticobasal degeneration with visual hallucination as an initial symptom: A case report.Kentaro Yoshida, Tadashi Adachi, Yuki Suzuki, Mayuko Sakuwa, Hiroki Fukuda, Masato Hasegawa, Yoshiki Adachi, Hiroshi Miura, Ritsuko Hanajima.Neuropathology. 2024 Jan 30. doi: 10.1111/neup.12963.
2023年
Atypical TDP-43 proteinopathy clinically presenting with progressive nonfluent aphasia: A case report.Yuki Suzuki, Tadashi Adachi, Kentaro Yoshida, Kenta Taneda, Mayuko Sakuwa, Masato Hasegawa, Ritsuko Hanajima.Neuropathology. 2023 Sep 17. doi: 10.1111/neup.12942.
Neuropathological analysis of cognitive impairment in progressive supranuclear palsy. Sakuwa M, Adachi T, Suzuki Y, Takigawa H, Hanajima R. J Neurol Sci. 2023 Jun 19;451:120718. doi: 10.1016/j.jns.2023.120718.
Neuropathological changes in advanced Parkinson’s disease. Tadashi Adachi, Ritsuko Hanajima. Neurology and Clinical Neuroscience.2023;22: 189-193.
[An autopsy case of polyarteritis nodosa accompanied with multiple immune-specific autoantibodies and rhabdomyolysis].Takeuchi M, Murakami T, Noguchi N, Tajiri Y, Kishi M, Sakuwa M, Kuwamoto S, Adachi T, Hanajima R.Rinsho Shinkeigaku. 2023 Jan 28;63(1):21-26. doi: 10.5692/clinicalneurol.cn-001782. Epub 2022 Dec 24.
2022年
An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.Suzuki Y, Adachi T, Sakuwa M, Sakata R, Takigawa H, Hasegawa M, Hanajima R.Neuropathology. 2022 Oct;42(5):447-452. doi: 10.1111/neup.12815. Epub 2022 Jul 10.
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.Tarutani A, Adachi T, Akatsu H, Hashizume Y, Hasegawa K, Saito Y, Robinson AC, Mann DMA, Yoshida M, Murayama S, Hasegawa M.Acta Neuropathol. 2022 Jun;143(6):613-640. doi: 10.1007/s00401-022-02426-3. Epub 2022 May 5.
2021年
First Japanese autopsy case showing LRRK2 mutation G2019S and TDP-43 proteinopathy.Sakuwa M, Adachi T, Suzuki Y, Yoshida K, Fukuda H, Miura H, Adachi Y, Hanajima R.Parkinsonism Relat Disord. 2021 Oct;91:85-87. doi: 10.1016/j.parkreldis.2021.09.009. Epub 2021 Sep 15.
An autopsy case of PARK2 due to a homozygous exon 2 deletion of parkin and associated with α-synucleinopathy. Sakuwa M, Adachi T, Yoshida K, Adachi Y, Nakano T, Hanajima R. Neuropathology. 2021 Aug;41(4):293-300. doi: 10.1111/neup.12735. Epub 2021 Jun 13.